PRESS RELEASE published on 02/17/2026 at 12:00, 4 months 1 day ago Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease Sanofi and Teva's duvakitug phase 2b maintenance data show durable efficacy in ulcerative colitis and Crohn's disease. Results reinforce ongoing phase 3 programs in UC and CD Ulcerative Colitis Sanofi Teva Crohn's Disease Duvakitug
BRIEF published on 02/16/2026 at 07:05, 4 months 2 days ago Beyfortus proves its effectiveness beyond the first season of VRS Sanofi VRS Beyfortus Infants Immunization
BRIEF published on 02/16/2026 at 07:05, 4 months 2 days ago Beyfortus Shows Extended Benefits for Infants Against RSV Infant Health Beyfortus Hospitalization Reduction RSV Immunization NIRSE-GAL Study
PRESS RELEASE published on 02/16/2026 at 07:00, 4 months 2 days ago Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season Universal RSV immunization with Beyfortus reduces hospitalizations in infants across two seasons, as per study in The Lancet Infectious Diseases and RSVVW '26 conference findings RSV Beyfortus Infants Immunization Hospitalizations
BRIEF published on 02/10/2026 at 15:05, 4 months 8 days ago Sanofi Finalizes Acquisition of Dynavax Acquisition Biopharma Sanofi Vaccines Dynavax
PRESS RELEASE published on 02/10/2026 at 15:00, 4 months 8 days ago Press Release: Sanofi completes the acquisition of Dynavax Sanofi completes acquisition of Dynavax, bolstering presence in adult immunization with HEPLISAV-B vaccine and Z-1018 shingles vaccine candidate, enhancing global reach and development capabilities Acquisition Sanofi Vaccine Immunization Dynavax
BRIEF published on 02/03/2026 at 07:05, 4 months 15 days ago Sanofi Signs €1 Billion Share Buyback Mandate Share Buyback Investment Financial Strategy Biopharma Sanofi
PRESS RELEASE published on 02/03/2026 at 07:00, 4 months 15 days ago Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion Sanofi signs share buyback mandate for up to €1 billion, intending to repurchase own shares between February 3, 2026, and December 31, 2026 Share Buyback Investment Sanofi Mandate €1 Billion
BRIEF published on 01/30/2026 at 13:05, 4 months 19 days ago The CHMP recommends approval of Sanofi's Rezurock for the treatment of chronic GVHD Treatment Sanofi Rezurock CHAMP GVHD
BRIEF published on 01/30/2026 at 13:05, 4 months 19 days ago Sanofi's Rezurock Recommended for EU Approval by CHMP Sanofi EU Market CHMP Approval Rezurock Chronic GVHD
Published on 06/19/2026 at 01:20, 1 hour 18 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 hour 31 minutes ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 2 hours 38 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/18/2026 at 23:55, 2 hours 43 minutes ago Relevant Gold Announces Results of Annual and Special General Meeting and Welcomes New Board Member
Published on 06/19/2026 at 01:15, 1 hour 23 minutes ago UV Laser Technology Gains Momentum in Europe for Clean, Cold Marking and High-Precision Engraving
Published on 06/18/2026 at 22:35, 4 hours 3 minutes ago Bitmine Immersion Technologies Announces Cash Dividend of $0.1056 per Share of 9.50% Series A Perpetual Preferred Stock
Published on 06/18/2026 at 22:00, 4 hours 38 minutes ago Blue Cap AG: Closing of the Acquisition of Janoschka AG Successfully Completed
Published on 06/18/2026 at 18:00, 8 hours 38 minutes ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 8 hours 53 minutes ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 9 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
Published on 06/18/2026 at 09:06, 17 hours 32 minutes ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany